Lina Souan, B.Sc., M.Sc., Ph.D., HCEL, HCOSP, D(ABMLI), received her M.Sc. in Microbiology from Pittsburgh University School of Medicine, Pittsburgh, PA (1996). Her Ph.D. was in Immunology (2001), and she completed her first post-doctoral fellowship in stem cell therapy for cancer at the Mayo Clinic, Rochester, Minnesota (2001-2003). Her second fellowship was at Sopherion Therapeutics in New Haven, Connecticut, where she worked on the patent Anti-Angiogenic Peptides and Methods of Use (2003-2004). She has been the Section Head of the Immunology Laboratory at King Hussein Cancer Center's Department of Pathology and Laboratory Medicine since 2005. She served as the Deputy Director and Chief Quality Officer of the KHCCBIO Cancer Biobank since 2011. She is a diplomat of the American Board of Medical Laboratory Immunology (ABMLI), a Healthcare Certified Executive Leader (HCEL), and a Jordanian Health Care Accreditation Council-certified Healthcare Certified Occupational Safety Professional (HCOSP). She serves as a reviewer for the International Union for Cancer Control (UICC) and a member of the American Society for Microbiology (ASM), the American Association for Clinical Chemistry (AACC), the Association of Medical Laboratory Immunologists (AMLI), the Jordanian Society for Medical Laboratory Sciences, the Jordanian Society of Allergy and Immunology, and a member of the American Association of Bioanalysts (AAB).